Ocugen is a biopharmaceutical brand that specializes in identifying and developing revolutionary science to provide unique healthcare solutions for various diseases and conditions. With a team of experienced leaders in biopharmaceutical research, commercialization, medicine, and operations, Ocugen is dedicated to making a significant impact on patient health. Led by Chairman, CEO, and Co-founder Dr.

Shankar Musunuri, who has more than 30 years of experience advancing and commercializing a diverse portfolio of products, Ocugen has a track record of success. Dr. Musunuri has held leadership roles at both established pharmaceutical companies and start-up biotechs.

Another Co-founder and Board member is Dr. Uday Kompella, a Professor of Pharmaceutical Sciences, Ophthalmology, and Bioengineering, whose research focuses on drug discovery and delivery for various disorders. Ocugen's commitment extends to collaborating with partners and fostering a culture of courage and innovation.

Located in Malvern, PA, they are continuously striving to revolutionize the healthcare landscape. Stay connected with Ocugen to be at the forefront of courageous innovation in healthcare